Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Translocation and Expression of CSF1 in Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor, Rheumatoid Arthritis and Other Reactive Synovitides

22 May 2007

Abstract excerpt

We recently demonstrated that CSF1, the ligand of the tyrosine kinase receptor, CSF1R, can be translocated in pigmented villonodular synovitis (PVNS) and tenosynovial giant cell tumor (TGCT). In this study, we evaluated the staining characteristics of PVNS/TGCT and reactive synovitides for CSF1 and CSF1R by in situ hybridization and immunohistochemistry on tissue microarrays and correlated these findings with the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous lymphoproliferative disorders research
Share to Musculoskeletal synovial abnormalities and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Sarcoma Diagnosis and Treatment

Source

Identifiers

PMID: 17527089
DOI: 10.1097/pas.0b013e31802b86f8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Translocation and Expression of CSF1 in Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor, Rheumatoid Arthritis and Other Reactive SynovitidesPMID 17527089Read ↗

Detection of CSF1 rearrangements deleting the 3′ UTR in tenosynovial giant cell tumorsSemantic proximity Read ↗

Single-cell RNA-seq analysis reveals aberrant CSF1 expression in disease-causing synovial fibroblasts of pigmented villonodular synovitisSemantic proximity Read ↗

Interactions in CSF1-driven Tenosynovial Giant Cell TumorsSemantic proximity Read ↗

Molecular Profiling of Atypical Tenosynovial Giant Cell Tumors Reveals Novel Non-CSF1 FusionsSemantic proximity Read ↗

Expanding the molecular spectrum of tenosynovial giant cell tumorsSemantic proximity Read ↗

Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutationsSemantic proximity Read ↗

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosisSemantic proximity Read ↗

Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by MacrophagesSemantic proximity Read ↗

Clinical Characteristics and Treatment Patterns of Tenosynovial Giant Cell Tumor in Japan: An Analysis of the Japanese Bone and Soft Tissue Tumor RegistrySemantic proximity Read ↗

Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.Semantic proximity Read ↗

Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis Pannus.Semantic proximity Read ↗

SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.